Skip to main content
. 2019 Sep 6;18(5):4974–4983. doi: 10.3892/ol.2019.10821

Figure 3.

Figure 3.

Figure 3.

Survival curves for the 69 patients who underwent pancreaticoduodenectomy for malignant tumors. (A) Survival rates between the PCG and NPCG groups were not significantly different (5-year overall survival, 40.7% vs. 42.4%; P=0.8773). (B) Survival rates between SPD and PPPD/SSPPD were also not significantly different (5-year overall survival, 44.4% vs. 41.0%; P=0.8199). PCG, pancreatic carcinoma group; NPCG, non-pancreatic carcinoma group; SPD, standard pancreatoduodenectomy; PPPD, pylorus-preserving pancreatoduodenectomy; SSPPD, subtotal stomach-preserving pancreatoduodenectomy.